Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistance

被引：28
|
作者：
Wang, SM
Ryder, H
Pretswell, I
Depledge, P
Milton, J
Hancox, TC
Dale, I
Dangerfield, W
Charlton, P
Faint, R
Dodd, R
Hassan, S
机构：
[1] Xenova Ltd, Dept Med Chem, Slough SL1 4NL, Berks, England
[2] Xenova Ltd, Dept Pharmacol, Slough SL1 4NL, Berks, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 04期
关键词：
D O I：
10.1016/S0960-894X(01)00804-6
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The syntheses and SAR studies of various quinazolinone compounds are described for the dual inhibition of Pgp and MRP1 in multidrug resistance. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：571 / 574
页数：4
相关论文
共 50 条
  • [41] Multidrug Resistance Mediated by MRP1 Gene Overexpression in Breast Cancer Patients
    Abaan, Ogan Demir
    Mutlu, Pelin Kaya
    Baran, Yusuf
    Atalay, Can
    Gunduz, Ufuk
    CANCER INVESTIGATION, 2009, 27 (02) : 201 - 205
  • [42] Kinetic analysis of rhodamines efflux mediated by the multidrug resistance protein (MRP1)
    Saengkhae, C
    Loetchutinat, C
    Garnier-Suillerot, G
    BIOPHYSICAL JOURNAL, 2003, 85 (03) : 2006 - 2014
  • [43] Prognostic significance of Pgp, MRP1, and MRP3 in ovarian cancer patients
    Sedlakova, I
    Laco, J.
    Tosner, J.
    Spacek, J.
    CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2015, 80 (06): : 405 - 413
  • [44] Functional dissection of the human multidrug resistance-associated protein (MRP1)
    Sarkadi, B
    Bakos, É
    Szakács, G
    Váradi, A
    FASEB JOURNAL, 1999, 13 (07) : A1356 - A1356
  • [45] Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1)
    Daoud, R
    Kast, C
    Gros, P
    Georges, E
    BIOCHEMISTRY, 2000, 39 (50) : 15344 - 15352
  • [46] Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of α,β-unsaturated carbonyl compounds
    Wortelboer, HM
    Usta, M
    van Zanden, JJ
    van Bladeren, PJ
    Rietjens, IMCM
    Cnubben, NHP
    BIOCHEMICAL PHARMACOLOGY, 2005, 69 (12) : 1879 - 1890
  • [47] The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis
    Hooijberg, JH
    Peters, GJ
    Assaraf, YG
    Kathmann, I
    Priest, DG
    Bunni, MA
    Veerman, AJP
    Scheffer, GL
    Kaspers, GJL
    Jansen, G
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (05) : 765 - 771
  • [48] Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human Glioma
    C. Calatozzolo
    M. Gelati
    E. Ciusani
    F. L. Sciacca
    B. Pollo
    L. Cajola
    C. Marras
    A. Silvani
    L. Vitellaro-Zuccarello
    D. Croci
    A. Boiardi
    A. Salmaggi
    Journal of Neuro-Oncology, 2005, 74 : 113 - 121
  • [49] Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of α,β-unsaturated carbonyl compounds
    Wortelboer, HM
    Usta, M
    van Zanden, JJ
    van Bladeren, PJ
    Rietjens, IMCM
    Cnubben, NHP
    DRUG METABOLISM REVIEWS, 2004, 36 : 60 - 60
  • [50] The interaction of curcumin and its glutathione conjugate with the multidrug resistance proteins MRP1 and MRP2
    Wortelboer, HM
    Usta, M
    van der Velde, AE
    van Zanden, JJ
    Rietjens, IMCM
    van Bladeren, PJ
    Cnubben, NHP
    DRUG METABOLISM REVIEWS, 2002, 34 : 92 - 92
12345